FAS and malignant colon neoplasm: In line with these data, inhibition of the PTPN13/FAS interaction with the SLV peptide in PTPN13-overexpressing CD133+ colon cancer stem cells increases their sensitivity to oxaliplatin, restoring FAS-induced apoptosis [51].